NEW YORK, July 10 - Pfizer has asked ActivX Biosciences to help it "further characterize" the protein activity of a certain undisclosed research compound currently being developed at Pfizer, ActivX said today.

Financial terms of the agreement were not announced.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

In a statement, National Institutes of Health Director Francis Collins says sexual harassment is "morally indefensible" and "unacceptable."

Octopuses might owe their intelligence to their liberal alterations to their genes, Cosmos reports.

Stat News and ProPublica report that African Americans are underrepresented in cancer clinical trials.

In Cell this week: genomic analysis of abdominal aortic aneurysm, effect of probiotics on the microbiome, and more.